生物活性傷口敷料市場規模、佔有率、成長分析(按產品類型、應用、最終用戶、作用機制、分銷管道和地區)- 2025-2032 年產業預測
市場調查報告書
商品編碼
1831582

生物活性傷口敷料市場規模、佔有率、成長分析(按產品類型、應用、最終用戶、作用機制、分銷管道和地區)- 2025-2032 年產業預測

Bioactive Wound Dressing Market Size, Share, and Growth Analysis, By Product Type (Antimicrobial Dressings, Hydrogels), By Application, By End User, By Mode of Action, By Distribution Channel, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 178 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計 2023 年全球生物活性傷口敷料市場價值將達到 42 億美元,從 2024 年的 46.6 億美元成長到 2032 年的 106.6 億美元,預測期內(2025-2032 年)的複合年成長率為 10.9%。

全球生物活性傷口敷料市場正經歷顯著成長,這得益於各種傷口(包括糖尿病足潰瘍、壓外科性創傷傷口、創傷性傷口和燒傷)的發生率不斷上升。市場從傳統敷料轉向生物活性替代品的轉變,主要源自於改善病患預後和縮短癒合時間的需求。人們日益意識到在醫院和家中進行適當創傷護理的重要性,這加速了生物活性敷料的普及。人口老化和慢性傷口(需要專門治療)的日益增多,進一步推動了市場擴張。光活化絲膠原膠原蛋白水凝膠等創新技術提供了無化學成分的解決方案,可提高癒合效率、促進濕潤環境、支持細胞遷移並減少發炎。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二次資料和一次資料方法
  • 市場規模預測
  • 市場假設與約束

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特的分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2024年)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

生物活性傷口敷料市場規模:依產品類型及複合年成長率(2025-2032)

  • 市場概況
  • 抗菌敷料
  • 水凝膠
  • 藻酸鹽
  • 形式
  • 膠原蛋白敷料
  • 銀基繃帶
  • 親水性纖維敷料敷料

生物活性傷口敷料市場規模:依應用與複合年成長率(2025-2032)

  • 市場概況
  • 慢性傷口
  • 急性傷口
  • 沐浴傷口覆蓋物
  • 手術傷口
  • 糖尿病足潰瘍
  • 壓瘡

生物活性傷口敷料市場規模(按最終用戶和複合年成長率分類)(2025-2032)

  • 市場概況
  • 醫院
  • 診所
  • 居家照護環境
  • 門診手術中心
  • 護理設施

生物活性傷口敷料市場規模:依作用機制及複合年成長率(2025-2032)

  • 市場概況
  • 抗菌作用
  • 抗發炎作用
  • 促進創傷治療
  • 濕度控制

生物活性傷口敷料市場規模:按分銷管道和複合年成長率(2025-2032)

  • 市場概況
  • 網上銷售
  • 藥局
  • 醫院
  • 超級市場/大賣場
  • 專賣店

生物活性傷口敷料市場規模及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2024年)
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 公司佔有率按部門分析
    • 收益同比比較(2022-2024 年)

主要企業簡介

  • Smith+Nephew(UK)
  • 3M(USA)
  • Organogenesis Inc.(USA)
  • ConvaTec Group plc(UK)
  • Molnlycke Health Care AB(Sweden)
  • Coloplast A/S(Denmark)
  • B. Braun Melsungen AG(Germany)
  • Cardinal Health(USA)
  • Integra LifeSciences Corporation(USA)
  • Johnson & Johnson(USA)
  • Medtronic plc(Ireland)
  • MiMedx Group, Inc.(USA)
  • Medline Industries, LP(USA)
  • Kerecis(Iceland)
  • Paul Hartmann AG(Germany)
  • URGO Medical(France)
  • Baxter International Inc.(USA)
  • Hollister Incorporated(USA)
  • Advanced Medical Solutions Group plc(UK)
  • Covalon Technologies Ltd.(Canada)

結論和建議

簡介目錄
Product Code: SQMIG35B2246

Global Bioactive Wound Dressing Market size was valued at USD 4.2 billion in 2023 and is poised to grow from USD 4.66 billion in 2024 to USD 10.66 billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

The global bioactive wound dressing market is witnessing substantial growth, fueled by the increasing incidence of various wounds, including diabetic foot ulcers, pressure ulcers, surgical and traumatic wounds, as well as burns. This market transition from conventional dressings to bioactive alternatives is primarily driven by the demand for enhanced patient outcomes and quicker healing times. Greater awareness of the importance of appropriate wound care in both hospital and home settings accelerates adoption. The aging population and rising prevalence of chronic wounds necessitate specialized treatments, further supporting market expansion. Innovations like photo-activated silk-collagen hydrogels enhance healing efficiency, offering a chemical-free solution that promotes a moist environment, supports cell migration, and reduces inflammation, aligning with the trend toward bioactive materials for optimal healing and user convenience.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioactive Wound Dressing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioactive Wound Dressing Market Segments Analysis

Global Bioactive Wound Dressing Market is segmented by Product Type, Application, End User, Mode of Action, Distribution Channel and region. Based on Product Type, the market is segmented into Antimicrobial Dressings, Hydrogels, Alginates, Foams, Collagen Dressings, Silver-based Dressings and Hydrofiber Dressings. Based on Application, the market is segmented into Chronic Wounds, Acute Wounds, Bus, Surgical Wounds, Diabetic Foot Ulcers and Pressure Ulcers. Based on End User, the market is segmented into Hospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers and Nursing Homes. Based on Mode of Action, the market is segmented into Antibacterial Action, Anti-inflammatory Action, Wound Healing Promotion and Moisture Control. Based on Distribution Channel, the market is segmented into Online Sales, Pharmacies, Hospitals, Supermarkets/Hypermarkets and Specialty Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioactive Wound Dressing Market

The global bioactive wound dressing market is primarily driven by the increasing prevalence of both acute and chronic wounds, including diabetic foot ulcers, pressure injuries, surgical wounds, and traumatic injuries. These types of wounds necessitate sophisticated care solutions to promote healing and prevent infections, thereby fueling the demand for advanced wound care products. Furthermore, the growing elderly population and the rise in lifestyle-related health conditions contribute significantly to the need for specialized wound care. This convergence of factors highlights the essential role that innovative bioactive wound dressings play in meeting the evolving needs of patients and healthcare providers alike.

Restraints in the Global Bioactive Wound Dressing Market

The global bioactive wound dressing market faces significant constraints due to the high costs associated with these advanced products compared to traditional wound care options. This pricing issue particularly affects small and medium-sized hospitals, especially in developing regions, where budget constraints lead to a preference for more economical alternatives. As a result, the uptake of bioactive dressings is limited, restricting market accessibility. To enhance their market presence and boost sales volumes, companies need to focus on strategies that reduce production costs and establish competitive pricing, thereby facilitating greater adoption of bioactive wound dressings across diverse healthcare settings.

Market Trends of the Global Bioactive Wound Dressing Market

The global bioactive wound dressing market is witnessing a significant trend driven by the rising demand for advanced antimicrobial dressings. As the prevalence of chronic and surgical wounds escalates, healthcare providers are increasingly opting for dressings infused with silver, honey, or iodine to effectively combat infection during the healing process. This shift underscores a growing recognition of the critical need for innovative wound care solutions, particularly within hospital settings, where the prevention of infection is paramount for enhancing patient outcomes. As a result, the bioactive wound dressing sector is poised for robust growth, focusing on delivering cutting-edge, effective treatment options.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Bioactive Wound Dressing Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Antimicrobial Dressings
  • Hydrogels
  • Alginates
  • Foams
  • Collagen Dressings
  • Silver-based Dressings
  • Hydrofiber Dressings

Global Bioactive Wound Dressing Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Chronic Wounds
  • Acute Wounds
  • Bus
  • Surgical Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers

Global Bioactive Wound Dressing Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Nursing Homes

Global Bioactive Wound Dressing Market Size by Mode of Action & CAGR (2025-2032)

  • Market Overview
  • Antibacterial Action
  • Anti-inflammatory Action
  • Wound Healing Promotion
  • Moisture Control

Global Bioactive Wound Dressing Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Online Sales
  • Pharmacies
  • Hospitals
  • Supermarkets/Hypermarkets
  • Specialty Stores

Global Bioactive Wound Dressing Market Size & CAGR (2025-2032)

  • North America (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • US
    • Canada
  • Europe (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Application, End User, Mode of Action, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Smith+Nephew (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Organogenesis Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MiMedx Group, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, LP (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerecis (Iceland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Paul Hartmann AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • URGO Medical (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hollister Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Medical Solutions Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Covalon Technologies Ltd. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations